clew medical logo

AvaSure Teams Up with CLEW Medical to Boost High-Acuity Care with AI-Driven Virtual Surveillance


The open AvaSure Virtual Care ecosystem enables the CLEW AI-powered, FDA-cleared predictive analytics solution for accurate early detection of patient deterioration in critical care

BELMONT, Mich. and BOSTON, June 5, 2024 /PRNewswire/ — AvaSure, a market leader in acute virtual care, and CLEW Medical, an AI-enabled clinical surveillance and predictive analytics company, announced their partnership to drive early detection of critical care patient deterioration, leading to more timely interventions, reduced complications, fewer readmissions, and decreased mortality. “We are thrilled to enhance intensive care units using our virtual care platform by partnering with CLEW’s advanced clinical surveillance solution,” said Adam McMullin, Chief Executive Officer, AvaSure. “AvaSure is dedicated to fostering an open ecosystem for virtual care, ensuring customers can benefit from a single, integrated platform. We continue to add high-value partners so our customers can maximize their investment and deliver high-quality virtual care tailored to the needs of patients at different acuity levels.”

Read More